RevoNA Bio
PrivateLast Round
Grant
Nov 1, 2023
Total Funding Raised
$1.39M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
RevoNA Bio operates in Healthcare & Life Sciences and is based in Walsall. Its latest recorded funding round was a Grant round in November 2023.
RevoNA Bio is a biotechnology company that develops an RNA-targeted pharmaceuticals discovery platform using AI-driven predictive engines to accelerate drug development.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, ML Platforms
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
RevoNA Bio Comparables
Compare RevoNA Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Serna Bio | 87% | |
| ReviR Therapeutics | 85% | |
| Atomic AI | 84% |
For institutional investors. Book with your work email.
RevoNA Bio Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
RevoNA Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Start Codon | Pre Seed |
| Innovate UK | Grant |
| Possible Ventures | Pre Seed |
| Discovery Park Ventures | Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 90% MoM.
- Apr 16, 2026
Monthly visitors grew 163% MoM, reaching 2.4K.
For institutional investors. Book with your work email.
RevoNA Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about RevoNA Bio's valuation, stock price, and market status.
Is RevoNA Bio a public or private company?
RevoNA Bio is a private company.
What is the current stock price of RevoNA Bio?
RevoNA Bio is a private company, so its shares have no public market price. Caplight tracks RevoNA Bio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is RevoNA Bio worth (valuation)?
Valuation information for RevoNA Bio is not publicly available.
Can I buy RevoNA Bio stock?
RevoNA Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was RevoNA Bio's last funding round?
RevoNA Bio's most recent funding round was Grant on November 1, 2023.
Who are the main investors in RevoNA Bio?
Key investors in RevoNA Bio include Start Codon, Innovate UK, Possible Ventures, Discovery Park Ventures.
Will RevoNA Bio IPO soon?
No public IPO plans have been announced for RevoNA Bio.
How can I track RevoNA Bio secondary market activity?
Caplight tracks bids, offers, and trades in RevoNA Bio's shares on secondary markets.